Stocks›Consumer Defensive›PM

PM Philip Morris International Inc.

NYSEResearch view

Philip Morris International Inc. operates in the Cigarettes industry.

$205.20+2.65%

Oct 16 close · 1D EOD · Databento

Consumer DefensiveCigarettesMega-capSEC EDGAR FY 2025-12-31

On the Wire · latest 3

All stories →

Aug 21 · Investing.comFDA authorizes 11 ZYN Ultra nicotine pouches for Philip MorrisThe FDA authorized 11 ZYN Ultra nicotine pouch products for Philip Morris, expanding the company's approved ZYN portfolio in the U.S. The decision removes a regulatory hurdle for a key growth brand.+1.72% next close
Jul 6 · NYT BusinessEfforts to Help Smokers Quit Stall Under TrumpThe CDC's tobacco control efforts have reportedly stalled, with its anti-smoking office closed and campaign ads pulled. This development suggests a potential tailwind for tobacco companies as public health initiatives to curb smoking diminish.
Jul 6 · NYT BusinessPhilip Morris and Altria race to capture surging nicotine pouch market led by ZynNicotine pouch demand, led by brands like Zyn, is surging, prompting tobacco giants to expand production and market share. This trend presents a growth opportunity for traditional tobacco companies, even as health warnings about addiction persist.

On the Wire · latest 3

All stories →

What happened

Daily closes · dots are Wire stories

1 story has a settled receipt so far (1 on the Wire). The record starts speaking at three.

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 21, 2025 and Oct 22, 2024, before the open.

Last report

Jul 22, 2026+3.33%

before the open

Last 4, next close

median 3.58% either way

up 3 of 4

Every report since 2022 →Earnings calendar →

DateEventSourceNext close

Aug 21FDA authorizes 11 ZYN Ultra nicotine pouches for Philip MorrisInvesting.comInvesting.com+1.72%
Jul 22Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗+3.33%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

12 big days in a year, and what we hold on each

A big day is a close more than 3.34% from the one before, three times PM’s median day (1.11%). On 3 of the 12, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±3.34%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayPMWhat we hold that dayGroup (median of 4) · each

1 Oct 21, 2025−3.83%
Resultsgroup −1.1%, did not move with it
1Oct 21, 2025−3.83%
ResultsFirst close after the Oct 21 results filing
−1.1% did not move with itXXII −1.9 · RLX −1.3 · MO −1.0 · ISPR +1.6
2 Nov 25, 2025+4.20%
Before our storiesgroup +2.8%, moved with PM
2Nov 25, 2025+4.20%
Before our stories
+2.8% moved with PMISPR +4.4 · XXII +3.8 · MO +1.8 · RLX +1.6
3 Jan 20, 2026−3.71%
Before our storiesgroup −1.4%, did not move with it
3Jan 20, 2026−3.71%
Before our stories
−1.4% did not move with itXXII −4.2 · RLX −1.7 · MO −1.0 · ISPR +9.1
4 Mar 5, 2026−5.22%
Before our storiesgroup −2.4%, did not move with it
4Mar 5, 2026−5.22%
Before our stories
−2.4% did not move with itRLX −3.4 · ISPR −3.1 · MO −1.7 · XXII −0.8
5 Mar 11, 2026−3.49%
Before our storiesgroup −2.2%, moved with PM
5Mar 11, 2026−3.49%
Before our stories
−2.2% moved with PMISPR −12.0 · XXII −3.2 · MO −1.2 · RLX −0.4
6 Mar 18, 2026−3.87%
Before our storiesgroup −2.6%, moved with PM
6Mar 18, 2026−3.87%
Before our stories
−2.6% moved with PMISPR −13.5 · MO −2.8 · RLX −2.5 · XXII 0.0
7 Apr 1, 2026−4.84%
Before our storiesgroup −0.6%, did not move with it
7Apr 1, 2026−4.84%
Before our stories
−0.6% did not move with itISPR −8.7 · MO −0.8 · RLX −0.5 · XXII 0.0
8 Apr 22, 2026+6.98%
Resultsgroup +3.0%, did not move with it
8Apr 22, 2026+6.98%
ResultsFirst close after the Apr 22 results filing
+3.0% did not move with itISPR +5.4 · RLX +5.3 · MO +0.8 · XXII −4.2
9 May 11, 2026+6.50%
Before our storiesgroup −2.2%, did not move with it
9May 11, 2026+6.50%
Before our stories
−2.2% did not move with itRLX +2.4 · MO +0.7 · ISPR −5.2 · XXII −6.1
10 May 26, 2026−3.95%
Before our storiesgroup −1.9%, did not move with it
10May 26, 2026−3.95%
Before our stories
−1.9% did not move with itMO −2.1 · RLX −1.9 · XXII −1.9 · ISPR +8.6
11 Jul 16, 2026+4.95%
Nothing on PMgroup −0.1%, did not move with it
11Jul 16, 2026+4.95%
Nothing on PMNo PM story, brief or results filing in our record that day
−0.1% did not move with itMO +3.6 · RLX +1.0 · XXII −1.1 · ISPR −1.6
12 Oct 8, 2026+4.05%
Nothing on PMgroup +1.2%, did not move with it
12Oct 8, 2026+4.05%
Nothing on PMNo PM story, brief or results filing in our record that day
+1.2% did not move with itISPR +3.5 · MO +2.9 · RLX −0.6 · XXII −2.3

A story on the same day is not a cause, and a group move is not proof either. Group: the median of MO, RLX, ISPR and XXII that day, the largest companies in PM’s SEC industry; “moved with PM” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). PM reports before the open, so day 1 is that day’s close. Each time, day 6 ended on the same side as day 1.

Reported Oct 21, 2025

day 1−3.83%day 6−5.22%

Reported Feb 6, 2026

day 1+0.45%day 6+3.03%

Reported Apr 22, 2026

day 1+6.98%day 6+6.17%

Reported Jul 22, 2026

day 1+3.33%day 6+5.53%

Next report: expected late OctoberEstimated from the dates of its last four results filings. Not announced. Since the Jul 22 report: +9.13%. Four reports is a small sample.

Every report since 2022 →

Each line is PM’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$319.8B

Revenue$40.6B+7.30%

Net income$11.3B

EPS, diluted$7.26+60.60%

Gross margin67.1%

Operating margin36.6%

Return on equity-141.4%

Debt / equity-2.26

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorConsumer Defensive

Market Cap$319.8B

Enterprise Value$333.1B

Income$11.3B

Sales$40.6B

Book/sh$-5.15

Cash/sh$3.14

Dividend TTM$5.64

Payout76%

Employees—

IPO—

Quick Ratio0.51

Current Ratio0.96

Debt/Eq-2.26

EPS (ttm)$7.26

EPS this Y60.6%

EPS past 3/5Y7.7%

Sales past 3/5Y8.6%

EPS Y/Y TTM60.6%

Sales Y/Y TTM7.3%

Shs Outstand1.56B

ROA16.4%

ROE-141.4%

ROIC228.0%

Gross Margin67.1%

Oper. Margin36.6%

Profit Margin27.9%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$31.4B

FY21

$31.8B

FY22

$35.2B

FY23

$37.9B

FY24

$40.6B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$31.4B	$31.8B	$35.2B	$37.9B	$40.6B
Gross Profit	$21.4B	$20.4B	$22.3B	$24.5B	$27.3B
Operating Income	$13.0B	$12.2B	$11.6B	$13.4B	$14.9B
Net Income	$9.1B	$9.0B	$7.8B	$7.1B	$11.3B
Diluted EPS	$5.83	$5.81	$5.02	$4.52	$7.26
Operating Cash Flow	$12.0B	$10.8B	$9.2B	$12.2B	$12.2B
Free Cash Flow	$11.2B	$9.7B	$7.9B	$10.8B	$10.7B

Same industry

PM against four tobacco peers, a year at 100

PM is up 29.8% in a year. All four did less: Altria Group (+15.5%), RLX Technology (−29.2%), Ispire Technology (−44.4%) and 22nd Century (−77.4%). Weekly closes, Oct 17, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

PM +29.8%. Altria Group +15.5%, RLX Technology −29.2%, Ispire Technology −44.4%, 22nd Century −77.4%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in PM’s SEC industry (Cigarettes) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

MO$125.4B RLX$2.6B ISPR$77M XXII$239,187

Follow the news. Track the move.

PM story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

Sector context/Market context

Aug 21

FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris

The FDA authorized 11 ZYN Ultra nicotine pouch products for Philip Morris, expanding the company's approved ZYN portfolio in the U.S. The decision removes a regulatory hurdle for a key growth brand.

Since story

+7.2%

2026-08-24 → 2026-10-16

Investing.com · 58d ago

View both sides →

Sector context/Market context

Jul 6

Efforts to Help Smokers Quit Stall Under Trump

The CDC's tobacco control efforts have reportedly stalled, with its anti-smoking office closed and campaign ads pulled. This development suggests a potential tailwind for tobacco companies as public health initiatives to curb smoking diminish.

Since story

+11.1%

2026-07-06 → 2026-10-16

NYT Business · 104d ago

View both sides →

Sector context/Market context

Jul 6

Philip Morris and Altria race to capture surging nicotine pouch market led by Zyn

Nicotine pouch demand, led by brands like Zyn, is surging, prompting tobacco giants to expand production and market share. This trend presents a growth opportunity for traditional tobacco companies, even as health warnings about addiction persist.

Since story

+11.1%

2026-07-06 → 2026-10-16

NYT Business · 104d ago

View both sides →

Follow the news. Track the move.

PM story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

Sector context/Market context

Aug 21

FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris

The FDA authorized 11 ZYN Ultra nicotine pouch products for Philip Morris, expanding the company's approved ZYN portfolio in the U.S. The decision removes a regulatory hurdle for a key growth brand.

Price history unavailable

Investing.com · 58d ago

View both sides →

Sector context/Market context

Jul 6